Repercussão clínica da reclassificação dos carcinomas diferenciados de tireóide de acordo com a 6ª edição do TNM

Varandas, Vanessa M; Coelho, Sabrina Mendes; Soeiro, Ana Paula V; Coeli, Cláudia Medina; Carvalho, Denise Pires de; Buescu, Alexandru; Vaisman, Mário.
Arq. bras. endocrinol. metab ; 51(5): 825-831, jul. 2007. ilus, tab
Artículo en Portugués | LILACS | ID: lil-461332

Documentos relacionados

  1. Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trial.
  2. Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.
  3. Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma.
  4. Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on the Outcomes of Lobectomy.
  5. Reply to "Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on the Outcomes of Lobectomy".
  6. Should small papillary thyroid cancer be observed? A population-based study.
  7. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
  8. Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: Should it also be reclassified in children?
  9. Follow-up and Outcomes of 186 Patients With Follicular Cell-Derived Thyroid Cancer Seen at a Referral Center by One Thyroidologist in 2015.
  10. Nonanaplastic follicular cell-derived thyroid carcinoma: mitosis and necrosis in long-term follow-up.